MiR-218-5p and miR-24-3p have also been reported to suppress the NK killing effect in CRC by targeting paxillin (PXN) (82) and in lung adenocarcinoma by targeting Serine Hydroxymethyltransferase 1 (SHMT1) (83), respectively. Here, PXN is linked to lung adenocarcinoma.